NYC Mayor Mamdani And Sen. Bernie Sanders Join New York Nurses On Picket Line

Michael M. Santiago/Getty Images

Limited Partners

Healthcare funds are winning the fight for investor dollars

Healthcare PE fundraising declined 4.2% last year, compared with a 31.2% plunge across all global PE funds.
NYC Mayor Mamdani And Sen. Bernie Sanders Join New York Nurses On Picket Line

Michael M. Santiago/Getty Images

Private equity fund managers specializing in healthcare have found it easier to raise money than their generalist peers in the last calendar year, according to PitchBook’s H2 2025 Healthcare Funds report.

While buyout funds that focus on sectors like life sciences, medical technology and biopharmaceuticals weren’t immune to private equity’s broader headwinds, the amount of capital they raised fell by 4.2% in 2025, from $19.1 billion to $18.3 billion, compared with a 31.2% drop for all global PE funds, PitchBook data shows.

These specialist managers were also more likely to close their funds at or above their targets than the average PE fund $5 billion or less in size.

Last year, 75.8% of healthcare PE funds hit their target size, and 36.4% exceeded it. During the same period, 72.6% of generalist PE funds under $5 billion met their targets, and 26.1% exceeded them.

Though a couple of healthcare buyout funds have raised more than $5 billion, including the largest ever, Patient Square Capital‘s $6 billion Fund II, most healthcare buyout funds are heavily focused on the middle market.

New York-based healthcare PE firm WindRose Health Investors, for example, closed its oversubscribed seventh fund at its $2.6 billion hard cap in December. Nordic investment firm Impilo closed its second fund at €700 million in less than seven months, and lower-middle-market buyout firm Hildred Capital Management closed its third vehicle dedicated to investing in medical devices, life sciences and pharmaceuticals with over $800 million in commitments, exceeding its $600 million target.

The resilience of healthcare buyout funds partly comes down to their superior returns, said Brian Wright, PitchBook’s lead analyst for healthcare research. Top-quartile healthcare PE funds have consistently outperformed the wider PE market across vintages from 2014 to 2020, according to a PitchBook analysis of total value to paid-in capital (TVPI). TVPI measures realized and unrealized gains as a multiple of invested capital.

Investors are also backing healthcare funds because the sector is one area where rapid advances in artificial intelligence could make companies more profitable by helping lower the administrative costs of healthcare systems, Wright said. In the US, healthcare systems spend approxiately $1 trillion annually on administrative expenses, significantly more than other high-income countries.

“I don’t know any other areas of the economy on the private equity side that are so significantly benefiting longer-term from AI,” Wright said.

Meanwhile, PE’s mega-funds—those with $5 billion or more in assets under management—saw the greatest fundraising success in 2025, with 78.6% of funds meeting their goals and 57.1% surpassing them.

LPs are consolidating their relationships at two ends of PE’s spectrum: top-quartile, specialist lower- and middle-market managers, and very large, multi-strategy investment platforms.

In 2025, 30% of LP respondents to a Goldman Sachs Asset Management survey said their private market commitments were fewer and larger compared to the previous year. Nearly half of the respondents said they look for specialization when backing a GP for the first time.

The survey also showed that 80% of LPs still prioritize fund performance and track record when committing to a manager for the first time, over factors such as diversification across sectors and regions, or broader product offerings.

Learn about our editorial standards.